N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients

[1] Members of the American College of Chest Physicians/ Society of Crit Care Med Consensus Conference Committee: American College of Chest Physicians/Society of Crit Care Med Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20 (1992) 864–874. http://dx.doi.org/10.1097/00003246-199206000-0002510.1097/00003246-199206000-00025Search in Google Scholar

[2] Ugarte, H., Silva, E., Mercan, D., De Mendonca, A. and Vincent J.L. Procalcitonin as a marker of infection in the intensive care unit. Crit. Care Med. 27 (1999) 498–504. http://dx.doi.org/10.1097/00003246-199903000-0002410.1097/00003246-199903000-00024Search in Google Scholar

[3] Wanner, G.A., Keel, M., Steckholzer, U., Beier, W., Stocker, R. and Ertel, W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit. Care Med. 28 (2000) 950–957. http://dx.doi.org/10.1097/00003246-200004000-0000710.1097/00003246-200004000-00007Search in Google Scholar

[4] Hoffmann, U., Brueckmann, M., Bertsch, T., Wiessner, M., Liebetrau, C., Lang, S., Haase, K.K., Borggrefe, M. and Huhle, G. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin. Lab. 51 (2005) 373–379. Search in Google Scholar

[5] Castillo, J.R., Zagler, A., Carrillo-Jimenez, R. and Hennekens, C.H. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int. J. Infect. Dis. 8 (2004) 271–274. http://dx.doi.org/10.1016/j.ijid.2003.12.00710.1016/j.ijid.2003.12.007Search in Google Scholar

[6] Charpentier, J., Luyt, C.E., Fulla, Y., Vinsonneau, C., Cariou, A., Grabar, S., Dhainaut, J.F., Mira, J.P. and Chiche, J.D. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med. 32 (2004) 660–665. http://dx.doi.org/10.1097/01.CCM.0000114827.93410.D810.1097/01.CCM.0000114827.93410.D8Search in Google Scholar

[7] Witthaut, R., Busch, C., Fraunberger, P., Walli, A., Seidel, D., Pilz, G., Stuttmann, R., Speichermann, N., Verner, L. and Werdan, K. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 29 (2003) 1696–1702. http://dx.doi.org/10.1007/s00134-003-1910-010.1007/s00134-003-1910-0Search in Google Scholar

[8] Nijsten, M.W., Olinga, P., The, T.H., de Vries, E.G., Koops, H.S., Groothuis, G.M., Limburg, P.C., Duis, H.J., Moshage, H., Hoekstra, H.J., Bijzet, J. and Zwaveling, J.H. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit. Care Med. 28 (2000) 586–588. http://dx.doi.org/10.1097/00003246-200002000-0005810.1097/00003246-200002000-00058Search in Google Scholar

[9] Bohuon, C. A brief history of PCT. Intensive Care Med. 26 (2000) 146–147. http://dx.doi.org/10.1007/s00134005113310.1007/s001340051133Search in Google Scholar

[10] Oberhoffer, M., Vogelsang, H., Jager, L. and Reinhart, K. Katacalcin and calcitonin immunoreactivity in different types of leukocytes. J. Crit. Care 14 (1999) 29–33. http://dx.doi.org/10.1016/S0883-9441(99)90005-910.1016/S0883-9441(99)90005-9Search in Google Scholar

[11] Gramm, H.J., Beier, W., Zimmermann, J., Oedra, N., Hannemann, L. and Boese-Ladgraf, J. Procalcitonin-A biological marker of inflammatory response with prognostic properties. Clin. Intens. Care 6 (1995) 71. Search in Google Scholar

[12] Zeni, F., Viallon, A., Assicot, M., Tardy, B., Vindimian, M. and Page, Y. Procalcitonin serum concentrations and severity of sepsis. Clin. Intens. Care 5 (1994) 89–98. Search in Google Scholar

[13] Hergert, M., Lestin, H.G., Scherkus, M., Brikner, K., Klett, I. and Stranz, G. Procalcitonin in patients with sepsis and polytrauma. Clin. Lab. 44 (1998) 659–670. Search in Google Scholar

[14] Oberhoffer, M., Biterlich, A., Hentschel, T., Meier-Hellmann, A., Vogelsang, H. and Reinhart, K. Procalcitonin (ProCT) correlates better with the ACCP/SCCM consensus conference definitions than other specific markers of the inflammatory response. Clin. Intens. Care 7 (1996) 46. Search in Google Scholar

[15] Oberhoffer, M., Vogelsang, H., Rasswurm, S., Hartung, T. and Reinhart, K. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin. Chem. Lab. Med. 37 (1999) 363–368. http://dx.doi.org/10.1515/CCLM.1999.06010.1515/CCLM.1999.060Search in Google Scholar PubMed

[16] Markuszewski, L., Rysz, J., Makowski, M., Debska, A. and Pietruszynski, R. C-reactive protein as a predictor of major adverse cardiac events (MACE) after percutaneous coronary intervention? Arch. Med. Sci. 1 (2005) 152–156. Search in Google Scholar

[17] Povoa, P., Almeida, E., Moreira, P., Fernandes, A., Mealha, R., Aragao, A. and Sabino, H. C-reactive protein as an indicator of sepsis. Intensive Care Med. 24 (1998) 1052–1056. http://dx.doi.org/10.1007/s00134005071510.1007/s001340050715Search in Google Scholar PubMed

[18] Brueckmann, M., Huhle, G., Lang, S., Haase, K.K., Bertsch, T., Weiss, C., Kaden, J.J., Putensen, C., Borggrefe, M. and Hoffmann, U. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112 (2005) 527–34 http://dx.doi.org/10.1161/CIRCULATIONAHA.104.47205010.1161/CIRCULATIONAHA.104.472050Search in Google Scholar PubMed

[19] Chua, G. and Kang-Hoe, L. Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit. Care 8 (2004) 248–250. http://dx.doi.org/10.1186/cc288910.1186/cc2889Search in Google Scholar PubMed PubMed Central

[20] Piechota, M., Irzmanski, R., Banach, M., Barylski, M., Ostrowski, S., Kowalski, J. and Pawlicki, L. Can impedance cardiography be routinely applied in patients with sepsis and severe sepsis? Arch. Med. Sci. 2 (2006) 114–121. Search in Google Scholar

[21] Pinilla, J.C., Hayes, P., Laverty, W., Arnold, C. and Laxdal, V. The Creactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 124 (1998) 799–805. http://dx.doi.org/10.1067/msy.1998.9136510.1067/msy.1998.91365Search in Google Scholar PubMed

[22] Waydhas, C., Nast-Kolb, D., Trupka, A., Zettl, R., Kick, M., Wiesholler, J., Schweiberer, L. and Jochum, M. Post-traumatic inflammatory response, secondary operations, and late multiple organ failure. J. Trauma 40 (1996) 624–630. Search in Google Scholar

[23] Rau, B., Steinbach, G., Baumgart, K., Gansauge, F., Grunert, A. and Beger, H.G. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit. Care Med. 28 (2000) 736–742. http://dx.doi.org/10.1097/00003246-200003000-0002210.1097/00003246-200003000-00022Search in Google Scholar PubMed

[24] Castelli, G.P., Pognani, C., Meisner, M., Stuani, A., Bellomi, D. and Sgarbi, L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit. Care Med. 8 (2004) 234–242. http://dx.doi.org/10.1186/cc287510.1186/cc2875Search in Google Scholar PubMed PubMed Central

[25] Tugrul, S., Esen, F., Celebi, S., Ozcan, P.E., Akinci, O., Cakar, N. and Telci, L. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth. Intensive Care 30 (2002) 747–754. Search in Google Scholar

[26] Hergert, M., Lestin, H.G., Scherkus, M., Brikner, K., Klett, I. and Stranz, G. Procalcitonin in patients with sepsis and polytrauma. Clin. Lab. 44 (1998) 659–670. Search in Google Scholar

[27] Piechota, M., Banach, M., Irzmanski, R., Barylski, M., Piechota-Urbanska, M., Kowalski, J., Pawlicki, L. Plasma endothelin-1 levels in septic patients. J. Intensive Care Med. 22 (2007), in press. 10.1177/0885066607301444Search in Google Scholar PubMed

[28] Pereira-Barretto, A.C., de Oliveira, M.T., Franco, F.G. and Cassaro-Strunz, C. ProBNP for stratifying patients with heart failure. Arq. Bras. Cardiol. 81 (2003) 239–248. http://dx.doi.org/10.1590/S0066-782X200300110000410.1590/S0066-782X2003001100004Search in Google Scholar PubMed

[29] Mueller, T., Gegenhuber, A., Poelz, W. and Haltmayer, M. Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NTproBNP Chemiluminescence Immunoassay: Implications for the Prediction of Symptomatic and Asymptomatic Structural Heart Disease. Clin. Chem. 49 (2003) 976–979. http://dx.doi.org/10.1373/49.6.97610.1373/49.6.976Search in Google Scholar PubMed

[30] Banach, M., Drozdz, J., Okonski, P. and Rysz, J. Immunological aspects of the statins’ function in patients with heart failure. The raport from the Annual Conference of ESC-Heart Failure 2005. Cell. Mol. Immunol. 2 (2005) 433–437. Search in Google Scholar

[31] Prontera, C., Emdin, M., Zucchelli, G.C., Ripoli, A., Passino, C. and Clerico, A. Analytical performance and diagnostic accuracy of a fullyautomated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Clin. Chem. Lab. Med. 42 (2004) 37–44. http://dx.doi.org/10.1515/CCLM.2004.00810.1515/CCLM.2004.008Search in Google Scholar PubMed

[32] Dahlstrom, U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur. J. Heart Fail. 6 (2004) 281–287. http://dx.doi.org/10.1016/j.ejheart.2004.01.00510.1016/j.ejheart.2004.01.005Search in Google Scholar PubMed

[33] Irzmanski, R., Banach, M., Piechota, M., Kowalski, J., Barylski, M., Cierniewski, C.S. and Pawlicki, L. Atrial, Brain Natriuretic Peptide and Endothelin-1 concentration in patients with idiopathic arterial hypertension. The dependence on the selected morphological parameters. Clin. Exp. Hypertens. 29 (2007), in press. 10.1080/10641960701361593Search in Google Scholar PubMed

[34] Phua, J., Lim, T.K. and Lee, K.H. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit. Care Med. 33 (2005) 2094–2113. http://dx.doi.org/10.1097/01.CCM.0000178351.03327.9F10.1097/01.CCM.0000178351.03327.9FSearch in Google Scholar PubMed

[35] Ma, K.K., Ogawa, T. and de Bold, A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by proinflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J. Mol. Cell. Cardiol. 36 (2004) 505–513. http://dx.doi.org/10.1016/j.yjmcc.2004.01.00110.1016/j.yjmcc.2004.01.001Search in Google Scholar PubMed

[36] Piechota, M., Irzmanski, R., Banach, M., Kowalski, J. and Pawlicki, L. Impedance cardiography in hemodynamic monitoring of septic patients: prospective study. Arch. Med. Sci. 3 (2007), in press. Search in Google Scholar

[37] Banach, M. The role of immunological factors in the induction of apoptosis of cardiomyocytes. Drug Pol. 13 (2003) 50–56. Search in Google Scholar